263 related articles for article (PubMed ID: 1311751)
1. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.
Hambleton P
J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751
[TBL] [Abstract][Full Text] [Related]
2. [Clostridium botulinum and botulinum neurotoxin].
Hirai Y
Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
[TBL] [Abstract][Full Text] [Related]
3. The action of batulinum toxin at the neuromuscular junction.
Sellin LC
Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
[TBL] [Abstract][Full Text] [Related]
4. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
Poulain B
Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin: bioweapon & magic drug.
Dhaked RK; Singh MK; Singh P; Gupta P
Indian J Med Res; 2010 Nov; 132(5):489-503. PubMed ID: 21149997
[TBL] [Abstract][Full Text] [Related]
7. The structure and mode of action of different botulinum toxins.
Dolly JO; Aoki KR
Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
[TBL] [Abstract][Full Text] [Related]
9. [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].
Poulain B; Humeau Y
Ann Readapt Med Phys; 2003 Jul; 46(6):265-75. PubMed ID: 12928128
[TBL] [Abstract][Full Text] [Related]
10. [The structure and mechanism of action of clostridial neurotoxins].
Parasion S; Bartoszcze M; Gryko R
Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
[TBL] [Abstract][Full Text] [Related]
11. Botulinum neurotoxins: mechanism of action and therapeutic applications.
Montecucco C; Schiavo G; Tugnoli V; de Grandis D
Mol Med Today; 1996 Oct; 2(10):418-24. PubMed ID: 8897436
[TBL] [Abstract][Full Text] [Related]
12. Distinction between Clostridium botulinum type A strains associated with food-borne botulism and those with infant botulism in Japan in intraintestinal toxin production in infant mice and some other properties.
Tabita K; Sakaguchi S; Kozaki S; Sakaguchi G
FEMS Microbiol Lett; 1991 Apr; 63(2-3):251-6. PubMed ID: 1905658
[TBL] [Abstract][Full Text] [Related]
13. Clostridium botulinum toxins: nature and preparation for clinical use.
Melling J; Hambleton P; Shone CC
Eye (Lond); 1988; 2 ( Pt 1)():16-23. PubMed ID: 3410136
[TBL] [Abstract][Full Text] [Related]
14. [Botulism: the agent, mode of action of the botulinum neurotoxins, forms of acquisition, treatment and prevention].
Marvaud JC; Raffestin S; Popoff MR
C R Biol; 2002 Aug; 325(8):863-78; discussion 879-83. PubMed ID: 12391898
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of action of botulinum toxins and neurotoxins].
Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
[TBL] [Abstract][Full Text] [Related]
17. The long journey of botulinum neurotoxins into the synapse.
Rummel A
Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
[TBL] [Abstract][Full Text] [Related]
18. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.
Bandyopadhyay S; Clark AW; DasGupta BR; Sathyamoorthy V
J Biol Chem; 1987 Feb; 262(6):2660-3. PubMed ID: 3029090
[TBL] [Abstract][Full Text] [Related]
19. [Botulism: structure and function of botulinum toxin and its clinical application].
Oguma K; Yamamoto Y; Suzuki T; Fatmawati NN; Fujita K
Nihon Rinsho; 2012 Aug; 70(8):1329-37. PubMed ID: 22894067
[TBL] [Abstract][Full Text] [Related]
20. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan.
Kozaki S; Nakaue S; Kamata Y
Microbiol Immunol; 1995; 39(10):767-74. PubMed ID: 8577267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
